Innoviva (INVA) Finished Goods (2013 - 2026)
Innoviva (INVA) posted Finished Goods of $4.1 million for Q1 2026, down 18.35% on a QoQ basis from $5.0 million in Q4 2025, and up 18.17% year-over-year from $3.4 million in Q1 2025.
Innoviva (INVA) Finished Goods (2013 - 2026) Analysis & Trends
Innoviva's Finished Goods history runs 7 years deep, the most recent figure standing at $4.1 million for Q1 2026.
- Quarterly Finished Goods rose 18.17% year-over-year to $4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.1 million (up 18.17% YoY) and the FY2025 annual result came in at $5.0 million, up 138.65% from the prior year.
- Finished Goods was $4.1 million for Q1 2026 at Innoviva, down from $5.0 million in the prior quarter.
- Across five years, Finished Goods topped out at $25.1 million in Q4 2022 and bottomed at $2.1 million in Q4 2024.
- A 5-year average of $9.6 million and a median of $5.3 million in 2025 frame the typical range for Finished Goods.
- Annual changes were most pronounced in 2024 — Finished Goods plunged 84.92% — and 2025, when it surged 138.65%.
- Innoviva's Finished Goods stood at $25.1 million in 2022, then slumped by 44.95% to $13.8 million in 2023, then sank by 84.92% to $2.1 million in 2024, then jumped by 138.65% to $5.0 million in 2025, then declined by 18.35% to $4.1 million in 2026.
- Business Quant data shows INVA's Finished Goods at $4.1 million in Q1 2026, $5.0 million in Q4 2025, and $5.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.06 Mn |
| Dec 31, 2025 | 4.97 Mn |
| Sep 30, 2025 | 5.32 Mn |
| Jun 30, 2025 | 4.30 Mn |
| Mar 31, 2025 | 3.44 Mn |
| Dec 31, 2024 | 2.08 Mn |
| Sep 30, 2024 | 4.31 Mn |
| Jun 30, 2024 | 4.34 Mn |
| Mar 31, 2024 | 7.72 Mn |
| Dec 31, 2023 | 13.81 Mn |
| Sep 30, 2023 | 18.43 Mn |
| Jun 30, 2023 | 14.12 Mn |
| Mar 31, 2023 | 21.36 Mn |
| Dec 31, 2022 | 25.09 Mn |
| Sep 30, 2022 | 10.92 Mn |
| Mar 31, 2014 | 4.79 Mn |
| Dec 31, 2013 | 4.91 Mn |
| Sep 30, 2013 | 1.35 Mn |